David Porter
- Virology top 2%
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism 21
- Nephrology top 2%
- Oncology top 5%
- Hepatology top 5%
- Hepatitis C virus research 9
-
- Biochemical and Molecular Research 19
- Cancer therapeutics and mechanisms 9
- Polyamine Metabolism and Applications 9
-
- HIV/AIDS drug development and treatment 16
-
- Nitric Oxide and Endothelin Effects 8
-
- BRCA gene mutations in cancer 7
- Co-authors
- Harold J. BrightJudith G. VoetSteven A. ShortT SpectorThomas SpectorJoan A. HarringtonFrank PreugschatB M Merrill
- Cited by
- VirologyBiochemistryNephrology
- Journals
- Journal of Biological Chemistry (36 papers)Biochemistry (10 papers)Biochemical Pharmacology (10 papers)
- Partner nations
- United StatesNew ZealandAustralia
In The Last Decade
David Porter
156 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 166
- Virology 265
- Biochemistry 388
- Nephrology 311
- Oncology 785
- Hepatology 212
Countries citing papers authored by David Porter
This map shows the geographic impact of David Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Porter more than expected).
Fields of papers citing papers by David Porter
This network shows the impact of papers produced by David Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Porter. The network helps show where David Porter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2016 | 18 | |
| 4 | 2016 | 10 | |
| 5 | Public health and clinical dilemmas resulting from imprecise vitamin D tests. | 2009 | 5 |
| 6 | 2008 | 47 | |
| 7 | Patterns of outcome and prognostic factors in primary bone lymphoma (osteolymphoma): A survey of 499 cases by the international extranodal lymphoma study group | 2007 | 3 |
| 8 | 2003 | 32 | |
| 9 | 2001 | 44 | |
| 10 | 2000 | 31 | |
| 11 | 2000 | 21 | |
| 12 | 1998 | 24 | |
| 13 | 1998 | 48 | |
| 14 | 1996 | 99 | |
| 15 | Attenuation of the antitumor activity of 5-fluorouracil by (R)-5-fluoro-5,6-dihydrouracil. | 1995 | 58 |
| 16 | 1995 | 63 | |
| 17 | 1995 | 41 | |
| 18 | 1995 | 2 | |
| 19 | 1994 | 38 | |
| 20 | 1992 | 54 |
About David Porter
David Porter is a scholar working on Biochemistry, Physiology and Nephrology, having authored 159 papers that have together received 4.1k indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (21 papers), Biochemical and Molecular Research (19 papers), HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (9 papers), Cancer therapeutics and mechanisms (9 papers), Polyamine Metabolism and Applications (9 papers), Nitric Oxide and Endothelin Effects (8 papers) and BRCA gene mutations in cancer (7 papers). The work is most often cited by research in Virology (265 citations), Biochemistry (388 citations) and Nephrology (311 citations). David Porter has collaborated with scholars based in United States, New Zealand and Australia. Frequent co-authors include Harold J. Bright, Judith G. Voet, Steven A. Short, T Spector, Thomas Spector, Joan A. Harrington, Frank Preugschat, B M Merrill, Theodore A. Alston and Janeen B. León. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Biochemical Pharmacology, Biochemical and Biophysical Research Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.